Free Trial

Koninklijke DSM (RDSMY) Stock Price, News & Analysis

+1.08 (+3.30%)
(As of 11/11/2022)
Today's Range
50-Day Range
52-Week Range
56,500 shs
Average Volume
116,034 shs
Market Capitalization
$23.67 billion
P/E Ratio
Dividend Yield
Price Target
RDSMY stock logo

About Koninklijke DSM Stock (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

RDSMY Stock Price History

RDSMY Stock News Headlines

Downing Strate. Share Chat
tired of SPENDING every weekend?
Did you know that instead of spending on the weekends, a very small group of informed traders are sometimes cashing out with their biggest gains? If you’re looking for a way to boost your trading to the next level, this could be the biggest trading video you watch this year.
Koninklijke DSM N.V. (DSM.DE)
Koninklijke DSM NV DSM
DSM2.BE - Koninklijke DSM NV
UBS maintains Koninklijke DSM at Buy
tired of SPENDING every weekend?
Did you know that instead of spending on the weekends, a very small group of informed traders are sometimes cashing out with their biggest gains? If you’re looking for a way to boost your trading to the next level, this could be the biggest trading video you watch this year.
Koninklijke DSM N.V. (DSM.AS)
Koninklijke DSM N.V.
Royal DSM: DSM - delivery of shares
DSM - delivery of shares
Koninklijke DSM NV (0NPP)
DSM provides nine months 2022 trading update
15 Most Valuable Dutch Companies in the World
Koninklijke DSM Earnings, Revenue Miss in Q2
DSM reports H1 2022 results
See More Headlines
Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Chemicals & allied products
Current Symbol
Previous Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.29 per share
Book Value
$11.78 per share


Free Float
Market Cap
$23.67 billion
Not Optionable
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Dimitri de Vreeze (Age 55)
    Co-CEO, COO & Member of the Managing Board
    Comp: $2.03M
  • Ms. Geraldine Matchett (Age 50)
    Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization
    Comp: $1.98M
  • Mr. Dave Huizing
    VP of Investor Relations
  • Ms. Lieke de Jong-Tops
    Sr. Communications Mang.
  • Mr. Rob J. Atsma (Age 76)
    Head of Energie Beheer Nederland
  • Mr. Paul Gilgen (Age 77)
    Head of Manufacturing & Purchasing of DSM Nutritional Products
  • Mr. Manfred Eggersdorfer (Age 71)
    Sr. VP of Nutrition Science & Advocacy
  • Mr. Bruno Müller (Age 66)
    Head of Strategy & VITAL Project - Nutritional Products
  • Mr. Jan Wolters (Age 79)
    Head of Fine Chemicals
  • Mr. Luca Rosetto (Age 59)
    Sr. VP of Operations - Nutritional Products

Should I Buy Koninklijke DSM Stock? RDSMY Pros and Cons Explained


Here are some ways that investors could benefit from investing in Koninklijke DSM:

  • Recent Developments: Koninklijke DSM has been investing heavily in sustainable solutions, positioning itself as a leader in the green economy. This focus on sustainability can attract environmentally conscious investors and potentially lead to long-term growth.
  • Diversified Portfolio: Koninklijke DSM has a diverse range of products and services across nutrition, health, and sustainable living sectors. This diversification can help mitigate risks associated with fluctuations in any single market segment.
  • Innovative Products: The company has a track record of developing innovative products, such as advanced materials and bio-based solutions. These products cater to evolving consumer demands and can drive revenue growth.
  • Strong Financial Performance: Koninklijke DSM has shown consistent financial growth, with strong revenue and profit margins. This stability can provide investors with confidence in the company's ability to deliver returns.
  • Stock Price: The current stock price of Koninklijke DSM is showing an upward trend, indicating positive market sentiment and potential for capital appreciation.


Investors should be bearish about investing in Koninklijke DSM for these reasons:

  • Market Volatility: The company operates in sectors that can be sensitive to economic fluctuations, which may impact its financial performance and stock price.
  • Regulatory Risks: Koninklijke DSM's operations are subject to various regulations related to product safety, environmental impact, and trade policies. Changes in regulations could affect the company's operations and profitability.
  • Competition: The industries in which Koninklijke DSM operates are highly competitive, with other major players constantly innovating and introducing new products. Intense competition could pressure the company's market share and margins.
  • Global Economic Conditions: Koninklijke DSM's performance is influenced by global economic conditions, including factors like GDP growth, inflation rates, and currency fluctuations. Economic downturns can impact demand for its products.
  • Supply Chain Disruptions: The company's operations rely on complex supply chains that can be vulnerable to disruptions, such as natural disasters, geopolitical events, or pandemics. Supply chain disruptions could affect production and distribution capabilities.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 8, 2024. Please send any questions or comments about these Koninklijke DSM pros and cons to

RDSMY Stock Analysis - Frequently Asked Questions

How have RDSMY shares performed in 2024?

Koninklijke DSM's stock was trading at $33.85 at the start of the year. Since then, RDSMY stock has increased by 0.0% and is now trading at $33.85.
View the best growth stocks for 2024 here

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) announced its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter.
Read the conference call transcript

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM (OTCMKTS:RDSMY) pays an annual dividend of $0.37 per share and currently has a dividend yield of 1.09%.
Read our dividend analysis for RDSMY.

How do I buy shares of Koninklijke DSM?

Shares of RDSMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RDSMY) was last updated on 6/24/2024 by Staff

From Our Partners